---
title: "Bama Tea climbs 6%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/305429996.md"
description: "Bama Tea rose 6.25% to HK$25.50. Up 29.44% over ten sessions and down 8.44% YTD."
datetime: "2026-11-13T07:57:44.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/305429996.md)
  - [en](https://longbridge.com/en/news/305429996.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/305429996.md)
generator: "portal-rs"
---

# Bama Tea climbs 6%

Bama Tea (6980.HK) climbed more than **6%** in Hong Kong trading to **HK$25.50**.

The stock is up 29.44% over the past ten sessions and down 8.44% year to date. It sits 51.70% above its 52-week low of HK$16.81.

The Hang Seng Index is down 3.53% over the past five sessions and down 7.85% year to date.

The packaged foods and meats industry index rose 1.1% over the same period.

The company recently entered into a framework agreement with related subsidiary Wang Xinji for the sale and purchase of tea products, covering the period from Jan. 1, 2027, to Dec. 31, 2029. The annual transaction caps are set at 3 million yuan for 2027, 5 million yuan for 2028, and 8 million yuan for 2029.

Based on public media reports. AI-generated; not investment advice.

### Related Stocks

- [06980.HK](https://longbridge.com/en/quote/06980.HK.md)

## Related News & Research

- [Bama Tea Files Next Day Disclosure Return to HKEX Announcing Share Buyback](https://longbridge.com/en/news/305807822.md)
- [Bama Tea expects H1 profit attributable to shareholders to rise at least 60%](https://longbridge.com/en/news/292328431.md)
- [Enterprise Says Partisan Spending Proposals May Complicate Housing Funding Deal](https://longbridge.com/en/news/306339503.md)
- [NRB's (KOSDAQ:475230) Earnings Are Weaker Than They Seem](https://longbridge.com/en/news/306339423.md)
- [INFINITT Healthcare's (KOSDAQ:071200) Shareholders Have More To Worry About Than Lackluster Earnings](https://longbridge.com/en/news/306338723.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**